Colosseum 65
7521 PP Enschede
The Netherlands
Tel: +31-53-4836410
Naslund Medical
Fiducial Markers (Gold Anchor) for use in any organ
Percutaneous implantation
- Prostate
- Lung
- Abdominal organs such as liver, pancreas, kidney, adrenal gland and metastases in various places
- Breast
- Cervix and other gynecologic organs
- Bladder wall
- Head & neck applications such as tonsil, nodules, base of tongue and close to the larynx
Naslund Medical AB, Sweden
Naslund Medical AB is a medical products company focused on the improved management and care of patients receiving radiation therapy.
As the pioneer and leader in developing new technology for fiducial markers, Naslund Medical markets Gold Anchor worldwide. Gold Anchor enables quicker and more effective radiation therapy treatment with increased patient safety.
Naslund Medical is based in Sweden with subsidiaries in the U.S. and France. JJ-MEDTECH is the distributor for Gold Anchor markers in the Netherlands.
A newly published phase II study in the Journal of Radiation Research included patients treated using either Gold Anchor® or VISICOIL™ fiducial markers.
Gold Anchor® and VISICOIL™ are now part of the same IZI Medical fiducial marker portfolio following IZI Medical’s recent acquisition of Naslund Medical.
A newly published phase II study in the Journal of Radiation Research included patients treated using either Gold Anchor® or VISICOIL™ fiducial markers. The study reports five-year outcomes of image-guided, moderately hypofractionated proton beam therapy for localized prostate cancer.
In the study, 125 patients received two intraprostatic fiducial markers – either Gold Anchor or VISICOIL – before CT simulation. The markers were matched daily using orthogonal kilovoltage X-ray images to support accurate patient positioning.
At five years, the researchers reported:
- A 3.3% cumulative incidence of grade ≥2 gastrointestinal adverse events
- An 8.1% cumulative incidence of grade ≥2 genitourinary adverse events
- A 97.6% biochemical recurrence-free rate
- No clinical recurrences
The authors hypothesized that fiducial marker-based image-guided radiotherapy, used with a shrunken-field technique, contributed to the favorable toxicity rate.
The study did not compare the performance of Gold Anchor and VISICOIL individually, but it provides another valuable example of fiducial marker-guided precision in prostate radiotherapy.
Fiducial Markers
Gold Anchor Fiducial Markers for use in any organ
Industry leading thin needles
Minimally invasive
Fine needles for cytology have been used more than 50 years in all parts of the body with no to very little harm. Gold Anchor markers come preloaded in needles of the same size.
Also on MRI, thanks to unique material
Great visibility
The marker is only 0.28 or 0.4 mm thick, which improves the surface-to-volume ratio. The marker is made of an alloy of gold and iron for improved MR visibility (pat. pend.).
Multiple cut-outs allow the marker to fold
Instant stability
Gold Anchor gets a great tissue attachment. The ball shaped marker becomes thicker than the needle tract and that prevents the marker from migrating in the needle tract when the needle is withdrawn.